Evidence map›Paper›PMID 33796896›Full record

ArticleJournal of neurology2021

Management considerations for stroke-like episodes in MELAS with concurrent COVID-19 infection.

Kuntal Sen, Dana Harrar, Andrea Hahn, Elizabeth M Wells, Andrea L Gropman

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Journal of neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Mitochondrial Medicine in the COVID-19 Era.Journal of clinical medicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kuntal SenCenter for Neuroscience and Behavioral Medicine, Children's National Hospital, Washington, DC, USA. ksen2@childrensnational.org.ORCID http://orcid.org/0000-0002-1197-923X
Dana HarrarCenter for Neuroscience and Behavioral Medicine, Children's National Hospital, Washington, DC, USA.
Andrea HahnDivision of Infectious Diseases, Children's National Hospital, Washington, DC, USA.
Elizabeth M WellsCenter for Neuroscience and Behavioral Medicine, Children's National Hospital, Washington, DC, USA.
Andrea L GropmanCenter for Neuroscience and Behavioral Medicine, Children's National Hospital, Washington, DC, USA.
Children's National · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There have been considerations since the beginning of the Coronavirus pandemic that COVID-19 infection, like any other viral illness, can trigger neurological and metabolic decompensation in patients with mitochondrial diseases. At the time of writing, there were no published reports reviewing experiences and guidelines about management of COVID-19 infection in this patient population. We present a challenging case of an adult patient with a known diagnosis of Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like Episodes (MELAS) complicated by COVID-19 infection. She initially presented with altered mental status and vomiting and went on to develop a stroke-like episode, pancreatitis, and pneumatosis intestinalis. We review salient features of her hospitalization, including initiation of thromboprophylaxis in relation to intravenous arginine therapy, caution regarding medications such as remdesivir, and the incidence of gastrointestinal complications.

Indexed as

Acidosis, LacticCOVID-19MELAS SyndromeStrokeVenous ThromboembolismAdultAnticoagulantsFemaleHumansSARS-CoV-2AnticoagulantsArginineCOVID-19MELASStroke-like episodes

Identifiers

PMID33796896
PMCPMC8016504
OpenAlexW3143088419

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.